HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 129 filers reported holding HERON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $29,873,000 | +16.9% | 1,606,942 | +53.7% | 1.75% | +9.7% |
| Q1 2019 | $25,550,000 | -7.1% | 1,045,392 | -1.4% | 1.59% | -24.5% |
| Q4 2018 | $27,491,000 | +2.8% | 1,059,792 | +25.4% | 2.11% | +42.8% |
| Q3 2018 | $26,746,000 | -23.8% | 845,042 | -6.5% | 1.48% | -26.0% |
| Q2 2018 | $35,115,000 | -14.7% | 903,857 | -39.4% | 1.99% | -6.0% |
| Q1 2018 | $41,167,000 | +52.2% | 1,491,569 | -0.2% | 2.12% | +70.8% |
| Q4 2017 | $27,044,000 | +11.5% | 1,494,175 | -0.5% | 1.24% | +16.2% |
| Q3 2017 | $24,244,000 | +8.6% | 1,501,177 | -6.9% | 1.07% | +12.4% |
| Q2 2017 | $22,327,000 | -9.5% | 1,612,102 | -1.9% | 0.95% | -24.2% |
| Q1 2017 | $24,662,000 | +20.5% | 1,644,152 | +5.2% | 1.25% | +30.5% |
| Q4 2016 | $20,473,000 | +82.6% | 1,562,817 | +140.2% | 0.96% | +180.2% |
| Q3 2016 | $11,212,000 | – | 650,731 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |